IP Library Granted Patent US 8,241,654
Granted Patent B2
US 8,241,654 · App. 12/548,524 · Granted Aug 14, 2012

Reactive surgical implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,241,654
App. No.
12/548,524
Granted
Aug 14, 2012
Kind
B2
Abstract

Biocompatible implants including a polymer substrate and a reactive component for implant fixation in situ. The reactive component in combination with the substrate creates a reactive implant which bonds to a tissue surface in situ.

Claims (12)

1. A medical device comprising:

a substrate in combination with a reactive component having at least one free reactive group, wherein the combination of the substrate and the reactive component create a reactive implant for chemically bonding the reactive implant with a tissue surface upon implantation, wherein the reactive component is present on the reactive implant in an amount of from about 0.05% by weight of the reactive implant to about 5% by weight of the reactive implant and wherein the reactive component is genipin.

2. The medical device of claim 1 , wherein the substrate comprises a material selected from the group consisting of gelatin, collagen, fibrin, fibrinogen, elastin, keratin, albumin, hydroxyethyl cellulose, cellulose, oxidized cellulose, hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose, trimethylene carbonate, caprolactone, dioxanone, glycolic acid, lactic acid, glycolide, lactide, polytetrafluoroethylenes, polyethylene terephthalate, polyurethanes, and combinations thereof.

3. The medical device of claim 1 , wherein the reactive component contacts the substrate in situ.

4. The medical device of claim 1 , wherein the reactive component is coated on at least a portion of a surface of the substrate.

5. The medical device of claim 1 , wherein the substrate and the reactive component are contacted in situ.

6. The medical device of claim 1 , wherein the reactive component comprises a solution at a concentration of from about 0.1% w/v to about 10% w/v.

7. The medical device of claim 1 , wherein the substrate is selected from the group consisting of sutures, staples, stents, meshes, tapes, gauzes, soft tissue repair devices, buttresses, bands, ribbons, grafts, scaffolds, wound dressings, and foams.

8. The medical device of claim 7 , wherein the medical device is a mesh.

9. The medical device of claim 1 , wherein the medical device further comprises a polymer coating.

10. The medical device of claim 1 , wherein the medical device further comprises a bioactive agent.

11. A reactive implant comprising a porous substrate in combination with a reactive component, wherein the reactive component includes a first reactive group that chemically bonds the reactive component to the porous substrate and a second reactive group that crosslinks the porous substrate to at least one tissue surface, wherein the reactive component is present on the reactive implant in an amount of from about 0.001% by weight of the reactive implant to about 10% by weight of the reactive implant, and wherein the reactive component is genipin.

Assignments (2)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2009
From: STOPEK, JOSHUA B.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 023154/0140 →